BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7881018)

  • 1. Nitric oxide-releasing non-steroidal anti-inflammatory drugs: a novel approach for reducing gastrointestinal toxicity.
    Wallace JL; Reuter BK; Cirino G
    J Gastroenterol Hepatol; 1994; 9 Suppl 1():S40-4. PubMed ID: 7881018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of gastrointestinal injury in acute endotoxic shock by flurbiprofen nitroxybutylester.
    Wallace JL; Cirino G; McKnight GW; Elliott SN
    Eur J Pharmacol; 1995 Jun; 280(1):63-8. PubMed ID: 7498255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel nonsteroidal anti-inflammatory drug derivatives with markedly reduced ulcerogenic properties in the rat.
    Wallace JL; Reuter B; Cicala C; McKnight W; Grisham MB; Cirino G
    Gastroenterology; 1994 Jul; 107(1):173-9. PubMed ID: 8020659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitric oxide-releasing NSAIDs inhibit interleukin-1beta converting enzyme-like cysteine proteases and protect endothelial cells from apoptosis induced by TNFalpha.
    Fiorucci S; Santucci L; Federici B; Antonelli E; Distrutti E; Morelli O; Renzo GD; Coata G; Cirino G; Soldato PD; Morelli A
    Aliment Pharmacol Ther; 1999 Mar; 13(3):421-35. PubMed ID: 10102977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastric tolerability and prolonged prostaglandin inhibition in the brain with a nitric oxide-releasing flurbiprofen derivative, NCX-2216 [3-[4-(2-fluoro-alpha-methyl-[1,1'-biphenyl]-4-acetyloxy)-3-methoxyphenyl]-2-propenoic acid 4-nitrooxy butyl ester].
    Wallace JL; Muscará MN; de Nucci G; Zamuner S; Cirino G; del Soldato P; Ongini E
    J Pharmacol Exp Ther; 2004 May; 309(2):626-33. PubMed ID: 14755007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of the nonsteroidal antiinflammatory drug flurbiprofen and its nitric oxide-releasing derivative, nitroflurbiprofen, on prostaglandin E(2), interleukin-1beta, and nitric oxide synthesis by activated microglia.
    Ajmone-Cat MA; Nicolini A; Minghetti L
    J Neurosci Res; 2001 Nov; 66(4):715-22. PubMed ID: 11746392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasorelaxant effect of nitric oxide releasing steroidal and nonsteroidal anti-inflammatory drugs.
    Keeble J; Al-Swayeh OA; Moore PK
    Br J Pharmacol; 2001 Aug; 133(7):1023-8. PubMed ID: 11487511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitric oxide-releasing NSAIDs: a novel class of GI-sparing anti-inflammatory drugs.
    Wallace JL; Pittman QJ; Cirino G
    Agents Actions Suppl; 1995; 46():121-9. PubMed ID: 7610982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of conventional and hydrogen sulfide-releasing non-steroidal anti-inflammatory drugs in rats with stress-induced and epinephrine-induced gastric damage.
    Fomenko I; Sklyarov A; Bondarchuk T; Biletska L; Panasyuk N; Wallace JL
    Stress; 2014 Dec; 17(6):528-37. PubMed ID: 25238023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physiological mediators in nonsteroidal anti-inflammatory drugs (NSAIDs)-induced impairment of gastric mucosal defense and adaptation. Focus on nitric oxide and lipoxins.
    Brzozowski T; Konturek PC; Pajdo R; Ptak-Belowska A; Kwiecien S; Pawlik M; Drozdowicz D; Sliwowski Z; Brzozowski B; Konturek SJ; Pawlik WW
    J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():89-102. PubMed ID: 18812631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of tumour necrosis factor-alpha and inducible nitric oxide synthase in the prevention of nitro-flurbiprofen small intestine toxicity.
    Bertrand V; Guimbaud R; Sogni P; Lamrani A; Mauprivez C; Giroud JP; Couturier D; Chauvelot-Moachon L; Chaussade S
    Eur J Pharmacol; 1998 Sep; 356(2-3):245-53. PubMed ID: 9774256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimation of acute flurbiprofen and ketoprofen toxicity in rat gastric mucosa at therapy-relevant doses.
    Holzer P; Jocic M; Cabré F; Mauléon D
    Inflamm Res; 2001 Dec; 50(12):602-8. PubMed ID: 11822786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flurbiprofen and HCT1026 protect mice against acute pancreatitis-associated lung injury.
    Huang J; Moochhala SM; Moore PK; Bhatia M
    Shock; 2005 Aug; 24(2):182-7. PubMed ID: 16044091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide-releasing nonsteroidal anti-inflammatory drugs: novel gastrointestinal-sparing drugs.
    Bandarage UK; Janero DR
    Mini Rev Med Chem; 2001 May; 1(1):57-70. PubMed ID: 12369991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NO-NSAIDs. Part 3: nitric oxide-releasing prodrugs of non-steroidal anti-inflammatory drugs.
    Borhade N; Pathan AR; Halder S; Karwa M; Dhiman M; Pamidiboina V; Gund M; Deshattiwar JJ; Mali SV; Deshmukh NJ; Senthilkumar SP; Gaikwad P; Tipparam SG; Mudgal J; Dutta MC; Burhan AU; Thakre G; Sharma A; Deshpande S; Desai DC; Dubash NP; Jain AK; Sharma S; Nemmani KV; Satyam A
    Chem Pharm Bull (Tokyo); 2012; 60(4):465-81. PubMed ID: 22466730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrointestinal mucosal injury following repeated daily oral administration of conventional formulations of indometacin and other non-steroidal anti-inflammatory drugs to pigs: a model for human gastrointestinal disease.
    Rainsford KD; Stetsko PI; Sirko SP; Debski S
    J Pharm Pharmacol; 2003 May; 55(5):661-8. PubMed ID: 12831509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastrointestinal safety of nitric oxide-derived aspirin is related to inhibition of ICE-like cysteine proteases in rats.
    Fiorucci S; Antonelli E; Santucci L; Morelli O; Miglietti M; Federici B; Mannucci R; Del Soldato P; Morelli A
    Gastroenterology; 1999 May; 116(5):1089-106. PubMed ID: 10220501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opposite effects of flurbiprofen and the nitroxybutyl ester of flurbiprofen on apoptosis in cultured guinea-pig gastric mucous cells.
    Johal K; Hanson PJ
    Br J Pharmacol; 2000 Jun; 130(4):811-8. PubMed ID: 10864887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between flurbiprofen and its nitric oxide-releasing derivatives HCT-1026 and NCX-2216 on Abeta(1-42)-induced brain inflammation and neuronal damage in the rat.
    Prosperi C; Scali C; Barba M; Bellucci A; Giovannini MG; Pepeu G; Casamenti F
    Int J Immunopathol Pharmacol; 2004; 17(3):317-30. PubMed ID: 15461866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NO-naproxen vs. naproxen: ulcerogenic, analgesic and anti-inflammatory effects.
    Davies NM; Røseth AG; Appleyard CB; McKnight W; Del Soldato P; Calignano A; Cirino G; Wallace JL
    Aliment Pharmacol Ther; 1997 Feb; 11(1):69-79. PubMed ID: 9042976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.